Karen Hambardzumyan
Solna, AB 17176, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Association of matrix metalloproteinase 7 and the alpha-chain of fibrinogen at baseline with response to methotrexate at 3 months in patients with early rheumatoid arthritis.
Journal: BMC rheumatology
Published: March 13, 2025
Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study.
Journal: Seminars in arthritis and rheumatism
Published: April 23, 2020
Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier.
Journal: Frontiers in immunology
Published: February 27, 2020
Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population.
Journal: Scandinavian journal of rheumatology
Published: June 28, 2019
Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies.
Journal: Current medical research and opinion
Published: February 20, 2019
Serum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT Trial.
Journal: The Journal of rheumatology
Published: October 09, 2018
Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial.
Journal: RMD open
Published: March 09, 2017
A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: February 22, 2016
Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.
Journal: RMD open
Published: October 14, 2015
Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 04, 2015
Response to: 'MBDA: what is it good for?' by Yazici et al.
Journal: Annals of the rheumatic diseases
Published: August 30, 2014
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
Journal: Annals of the rheumatic diseases
Published: November 27, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026